![]() | ||||
TISG: Initiated Stock Coverage Report Healthy Prospects for Tri-Isthmus Group Click here to download the report. We are initiating coverage of Tri-Isthmus Group Inc., (Pink Sheets: TISG) with a Buy rating and near-term price range of $0.56 to $0.71 and a long-term target of $1.19 to $1.59. The company is rapidly building a healthcare facility business with attractive operating margins by acquiring and operating profitable or near profitable rural hospitals and ambulatory surgical centers in partnership with physicians. The company has raised approximately $12 million for acquisitions since its formation in mid-2005. To date, the company has acquired six facilities and taken its annual revenue run rate to $40 million from $3 million one year ago. It now has more than 350 employees in Oklahoma and California. The company’s balance sheet reflects over $29 million in assets. Key Points Focus on Rural Areas: In rural communities, hospitals are typically the primary source of healthcare and are usually the sole providers. This results in limited competition. Many rural hospitals are also reimbursed on a cost-plus-basis from Medicare, which allows full expenses recovery. Rural hospitals are able to obtain higher margins than their urban counterparts due to the following reasons: |
Pink Sheets: TISG
|
| ||||